Author: admin

Flock CEO defends surveillance technology amid national backlash: ‘We shouldn’t pause progress’

Flock CEO defends surveillance technology amid national backlash: ‘We shouldn’t pause progress’ At TechCrunch Disrupt, Flock CEO Garrett Langley defended his company’s surveillance technology despite growing privacy concerns, arguing that its crime-fighting benefits outweigh the risks of abuse. Powered by WPeMatico https://techcrunch.com/2026/10/14/flock-ceo-defends-surveillance-technology-amid-national-backlash-we-shouldnt-pause-progress/

Meet the five companies competing in the Startup Battlefield finals at Disrupt 2026

Meet the five companies competing in the Startup Battlefield finals at Disrupt 2026 It’s time to unveil the five companies that will be competing in the Startup Battlefield finals. Powered by WPeMatico https://techcrunch.com/2026/10/14/meet-the-five-companies-competing-in-the-startup-battlefield-finals-at-disrupt-2026/

Ricursive Intelligence is betting on AI-designed chips to help solve the compute crisis

Ricursive Intelligence is betting on AI-designed chips to help solve the compute crisis The founders detailed how their startup is developing AI that can design chips, learn from each iteration, and improve subsequent designs, all with the goal of automating and accelerating the chip design process. Powered by WPeMatico https://techcrunch.com/2026/10/14/ricursive-intelligence-is-betting-on-ai-designed-chips-to-help-solve-the-compute-crisis/

Gudea leverages AI to help organizations prevent social media crises before they erupt

Gudea leverages AI to help organizations prevent social media crises before they erupt Every day, conversations unfold across social media and websites around the world. A seemingly insignificant post—whether it involves AI-generated misinformation, hate speech, or a damaging rumor—can quickly snowball into a much larger public controversy. Gudea, a company

Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Intero Biosystems wants drugmakers to test on mini human intestines, not animals Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology. Powered by WPeMatico https://techcrunch.com/2026/10/14/intero-biosystems-wants-drugmakers-to-test-on-mini-human-intestines-not-animals/

UK launches refugee-focused venture fund with initial £300,000 investment

UK launches refugee-focused venture fund with initial £300,000 investment Today marks the launch of the Refugee Venture Fund (RVF), a new UK venture capital fund dedicated exclusively to investing in high-growth businesses founded by refugees. Launching with £300,000 in initial capital, with plans to increase this to £500,000, the Fund

Accenture acquires UK customer intelligence firm Sagacity to strengthen AI and data capabilities

Accenture acquires UK customer intelligence firm Sagacity to strengthen AI and data capabilities Accenture has acquired Sagacity, a UK-based data and customer intelligence firm. Founded in 2005 and headquartered in London, Sagacity brings differentiated data assets, AI-enabled technology and deep customer intelligence expertise.  The company specialises in analysing customer data